Literature DB >> 29141220

Phosphorylation and Ubiquitination Regulate Protein Phosphatase 5 Activity and Its Prosurvival Role in Kidney Cancer.

Natela Dushukyan1, Diana M Dunn1, Rebecca A Sager1, Mark R Woodford2, David R Loiselle3, Michael Daneshvar2, Alexander J Baker-Williams1, John D Chisholm4, Andrew W Truman5, Cara K Vaughan6, Timothy A Haystead3, Gennady Bratslavsky2, Dimitra Bourboulia1, Mehdi Mollapour7.   

Abstract

The serine/threonine protein phosphatase 5 (PP5) regulates multiple cellular signaling networks. A number of cellular factors, including heat shock protein 90 (Hsp90), promote the activation of PP5. However, it is unclear whether post-translational modifications also influence PP5 phosphatase activity. Here, we show an "on/off switch" mechanism for PP5 regulation. The casein kinase 1δ (CK1δ) phosphorylates T362 in the catalytic domain of PP5, which activates and enhances phosphatase activity independent of Hsp90. Overexpression of the phosphomimetic T362E-PP5 mutant hyper-dephosphorylates substrates such as the co-chaperone Cdc37 and glucocorticoid receptor in cells. Our proteomic approach revealed that the tumor suppressor von Hippel-Lindau protein (VHL) interacts with and ubiquitinates K185/K199-PP5 for proteasomal degradation in a hypoxia- and prolyl-hydroxylation-independent manner. Finally, VHL-deficient clear cell renal cell carcinoma (ccRCC) cell lines and patient tumors exhibit elevated PP5 levels. Downregulation of PP5 causes ccRCC cells to undergo apoptosis, suggesting a prosurvival role for PP5 in kidney cancer.
Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  PP5; VHL; casein kinase-1 δ; clear cell renal cell carcinoma; co-chaperone; heat shock protein 90; kidney cancer; molecular chaperone; serine/threonine phosphatase 5; von Hippel-Lindau protein

Mesh:

Substances:

Year:  2017        PMID: 29141220      PMCID: PMC5699234          DOI: 10.1016/j.celrep.2017.10.074

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  40 in total

Review 1.  Impact of Posttranslational Modifications on the Anticancer Activity of Hsp90 Inhibitors.

Authors:  Mark R Woodford; Diana Dunn; Jonelle B Miller; Sami Jamal; Len Neckers; Mehdi Mollapour
Journal:  Adv Cancer Res       Date:  2015-10-23       Impact factor: 6.242

2.  Serine/threonine protein phosphatase type 5 acts upstream of p53 to regulate the induction of p21(WAF1/Cip1) and mediate growth arrest.

Authors:  Z Zuo; N M Dean; R E Honkanen
Journal:  J Biol Chem       Date:  1998-05-15       Impact factor: 5.157

3.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

4.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

5.  HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.

Authors:  M Ivan; K Kondo; H Yang; W Kim; J Valiando; M Ohh; A Salic; J M Asara; W S Lane; W G Kaelin
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

6.  Inhibition of protein phosphatase 5 (PP5) suppresses survival and growth of colorectal cancer cells.

Authors:  Jianwei Wang; Jinhui Zhu; Mingjun Dong; Hua Yu; Xiaoyu Dai; Keqiang Li
Journal:  Biotechnol Appl Biochem       Date:  2015-01-14       Impact factor: 2.431

7.  Ser/Thr protein phosphatase 5 inactivates hypoxia-induced activation of an apoptosis signal-regulating kinase 1/MKK-4/JNK signaling cascade.

Authors:  Guofei Zhou; Teresa Golden; Ileana V Aragon; Richard E Honkanen
Journal:  J Biol Chem       Date:  2004-08-24       Impact factor: 5.157

8.  Activated Rac1 GTPase translocates protein phosphatase 5 to the cell membrane and stimulates phosphatase activity in vitro.

Authors:  Anindya Chatterjee; Ling Wang; David L Armstrong; Sandra Rossie
Journal:  J Biol Chem       Date:  2009-11-30       Impact factor: 5.157

9.  Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function.

Authors:  C E Stebbins; W G Kaelin; N P Pavletich
Journal:  Science       Date:  1999-04-16       Impact factor: 47.728

10.  Selective activators of protein phosphatase 5 target the auto-inhibitory mechanism.

Authors:  Veronika Haslbeck; Adrian Drazic; Julia M Eckl; Ferdinand Alte; Martin Helmuth; Grzegorz Popowicz; Werner Schmidt; Frank Braun; Matthias Weiwad; Gunter Fischer; Gerd Gemmecker; Michael Sattler; Frank Striggow; Michael Groll; Klaus Richter
Journal:  Biosci Rep       Date:  2015-04-20       Impact factor: 3.840

View more
  17 in total

1.  Di-Ras2 promotes renal cell carcinoma formation by activating the mitogen-activated protein kinase pathway in the absence of von Hippel-Lindau protein.

Authors:  Hanyu Rao; Xuefeng Li; Min Liu; Jing Liu; Xiaoxue Li; Jin Xu; Li Li; Wei-Qiang Gao
Journal:  Oncogene       Date:  2020-03-11       Impact factor: 9.867

2.  The Antitumor Drug LB-100 Is a Catalytic Inhibitor of Protein Phosphatase 2A (PPP2CA) and 5 (PPP5C) Coordinating with the Active-Site Catalytic Metals in PPP5C.

Authors:  Brandon M D'Arcy; Mark R Swingle; Cinta M Papke; Kevin A Abney; Erin S Bouska; Aishwarya Prakash; Richard E Honkanen
Journal:  Mol Cancer Ther       Date:  2019-01-24       Impact factor: 6.261

Review 3.  Not quite the SSAme: unique roles for the yeast cytosolic Hsp70s.

Authors:  Sarah K Lotz; Laura E Knighton; Gary W Jones; Andrew W Truman
Journal:  Curr Genet       Date:  2019-04-24       Impact factor: 3.886

4.  Aromatase Acetylation Patterns and Altered Activity in Response to Sirtuin Inhibition.

Authors:  Deborah Molehin; Isabel Castro-Piedras; Monica Sharma; Souad R Sennoune; Daphne Arena; Pulak R Manna; Kevin Pruitt
Journal:  Mol Cancer Res       Date:  2018-06-19       Impact factor: 5.852

5.  PTPN22 phosphorylation acts as a molecular rheostat for the inhibition of TCR signaling.

Authors:  Shen Yang; Mattias N D Svensson; Nathaniel H O Harder; Wan-Chen Hsieh; Eugenio Santelli; William B Kiosses; James J Moresco; John R Yates; Charles C King; Lin Liu; Stephanie M Stanford; Nunzio Bottini
Journal:  Sci Signal       Date:  2020-03-17       Impact factor: 8.192

Review 6.  Structure and function of the co-chaperone protein phosphatase 5 in cancer.

Authors:  Rebecca A Sager; Natela Dushukyan; Mark Woodford; Mehdi Mollapour
Journal:  Cell Stress Chaperones       Date:  2020-04-02       Impact factor: 3.667

Review 7.  VHL and Hypoxia Signaling: Beyond HIF in Cancer.

Authors:  Jing Zhang; Qing Zhang
Journal:  Biomedicines       Date:  2018-03-19

8.  Long noncoding RNA lnc-DILC stabilizes PTEN and suppresses clear cell renal cell carcinoma progression.

Authors:  Han Zhang; Pengtao Wei; Wenwei Lv; Xingtao Han; Jinhui Yang; Shuaifeng Qin
Journal:  Cell Biosci       Date:  2019-10-02       Impact factor: 7.133

Review 9.  Oligomerization of Hsp70: Current Perspectives on Regulation and Function.

Authors:  Jade E Takakuwa; Laura E Knighton; Andrew W Truman
Journal:  Front Mol Biosci       Date:  2019-09-04

10.  Post-translational Regulation of FNIP1 Creates a Rheostat for the Molecular Chaperone Hsp90.

Authors:  Rebecca A Sager; Mark R Woodford; Sarah J Backe; Alan M Makedon; Alexander J Baker-Williams; Bryanna T DiGregorio; David R Loiselle; Timothy A Haystead; Natasha E Zachara; Chrisostomos Prodromou; Dimitra Bourboulia; Laura S Schmidt; W Marston Linehan; Gennady Bratslavsky; Mehdi Mollapour
Journal:  Cell Rep       Date:  2019-01-29       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.